Star Health & Allied Insurance Co. Ltd. AI Stock Analysis
Want to see IN:STARHEALTH full AI Analyst Report?
Star Health & Allied Insurance Co. Ltd. (STARHEALTH) AI Stock Analysis
Star Health & Allied Insurance Co. Ltd.
(NSE:STARHEALTH)
The score is driven primarily by solid financial performance (profitability recovery, strong recent cash generation, and low leverage), but is held back by slowing growth and cooling earnings/returns since 2024. Technical indicators are neutral with a negative MACD, and valuation is less compelling with a 31.532 P/E and no dividend yield provided.
Star Health & Allied Insurance Co. Ltd. (STARHEALTH) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 328.65B
- Dividend Yield
- ―
- Average Volume (3M)
- 50.22K
- Price to Earnings (P/E)
- 31.3
- Beta (1Y)
- 0.72
- Revenue Growth
- 20.54%
- EPS Growth
- 97.48%
- Country
- India
- Employees
- 18,566
- Sector
- General
- Sector Strength
- 55
- Industry
- Insurance - Life
Star Health & Allied Insurance Co. Ltd. Business Overview & Revenue Model
Company Description
Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group hea...
How the Company Makes Money
STARHEALTH primarily makes money through its health insurance underwriting and the investment of funds generated from its insurance operations. Its key revenue stream is premium income collected from policyholders across retail health plans (individu...
Star Health & Allied Insurance Co. Ltd. Financial Statement Overview
Summary
Fundamentals are solid: steady multi-year revenue scaling and a clear profitability recovery after 2021–2022 losses, supported by strong recent operating cash flow/free cash flow and low leverage. Offsetting this, growth slowed materially in 2026 and earnings/returns have stepped down from the 2024 peak, signaling some recent margin/underwriting pressure.
Income Statement
72PositiveBalance Sheet
82Very PositiveCash Flow
79Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 201.34B | 178.33B | 164.88B | 144.13B | 122.41B | 106.02B |
| Gross Profit | 75.09B | 64.58B | 138.61B | 121.61B | 104.13B | 91.10B |
| EBITDA | 14.46B | 7.54B | 9.98B | 12.68B | 9.67B | -13.05B |
| Net Income | 10.54B | 5.57B | 6.46B | 8.45B | 6.19B | -10.41B |
Balance Sheet | ||||||
| Total Assets | 242.93B | 240.64B | 207.85B | 180.54B | 163.58B | 152.79B |
| Cash, Cash Equivalents and Short-Term Investments | 3.38B | 14.44B | 6.58B | 13.68B | 10.49B | 12.11B |
| Total Debt | 756.10M | 4.70B | 4.70B | 4.70B | 4.70B | 7.20B |
| Total Liabilities | 138.57B | 165.13B | 136.72B | 113.23B | 97.69B | 88.83B |
| Stockholders Equity | 104.36B | 75.51B | 71.12B | 67.32B | 65.89B | 63.96B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 17.54B | 12.96B | 11.86B | 12.29B | -340.86M |
| Operating Cash Flow | 0 | 18.32B | 13.79B | 13.10B | 12.76B | 290.43M |
| Investing Cash Flow | 0 | -10.67B | -11.51B | -11.77B | -10.97B | -37.86B |
| Financing Cash Flow | 0 | 96.50M | -42.00M | 229.73M | -2.68B | 25.36B |
Star Health & Allied Insurance Co. Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:STARHEALTH, the sentiment is Positive. The current price of 560.20 is above the 20-day moving average (MA) of 544.08, above the 50-day MA of 548.73, and above the 200-day MA of 529.33, indicating a bullish trend. The MACD of 4.22 indicates Negative momentum. The RSI at 54.08 is Neutral, neither overbought nor oversold. The STOCH value of 63.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:STARHEALTH.
Star Health & Allied Insurance Co. Ltd. Peers Comparison
Overall Rating
IN:ICICIGI80Outperform
IN:STARHEALTH66Neutral
IN:NIACL63Neutral
IN:MEDIASSIST59Neutral
IN:NIVABUPA55Neutral
IN:MAXIND45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | INR 843.76B | 32.13 | ― | 0.87% | 13.84% | -9.23% | |
| 66Neutral | INR 329.75B | 31.26 | ― | ― | 20.54% | 97.48% | |
| 63Neutral | INR 254.95B | -46.19 | ― | 1.00% | 9.00% | -146.09% | |
| 59Neutral | INR 21.23B | 19.62 | ― | 0.70% | 20.27% | 24.08% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 136.54B | 25.63 | ― | ― | 58.19% | 467.19% | |
| 45Neutral | INR 8.25B | -6.43 | ― | ― | 61.46% | 28.38% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:STARHEALTH | Star Health & Allied Insurance Co. Ltd. | 560.20 | 69.50 | 14.16% | |
| IN:ICICIGI | ICICI Lombard General Insurance Co. Ltd. | 1643.00 | -344.87 | -17.35% | |
| IN:MAXIND | Max India Ltd | 146.40 | -47.80 | -24.61% | |
| IN:MEDIASSIST | Medi Assist Healthcare Services Limited | 284.25 | -176.19 | -38.27% | |
| IN:NIACL | New India Assurance Co. Ltd. | 149.65 | -23.67 | -13.66% | |
| IN:NIVABUPA | Niva Bupa Health Insurance Company Limited | 73.82 | -1.72 | -2.28% |
Star Health & Allied Insurance Co. Ltd. Corporate Events
Star Health Board Clears Shift of Sthitaprajna Advisors From Promoter to Public Shareholder
Star Health & Allied Insurance Co. Ltd., a leading Chennai-based health insurer listed on BSE and NSE, focuses on retail and group health insurance and allied products for individual and corporate customers across India. The company operates under ov...
Star Health releases Q2 and H1 FY 2027 investor presentation ahead of earnings call
Star Health & Allied Insurance Co. Ltd., headquartered in Chennai, is a listed health insurer providing retail and corporate medical coverage and allied insurance services across the Indian market. Its shares trade on both BSE and the National Stock...
Star Health Plans Tokyo Meetings to Deepen Ties With Japanese Institutional Investors
Star Health & Allied Insurance has scheduled a series of one-on-one in-person meetings with major Japanese institutional investors and asset managers in Tokyo on September 28, 2026. The sessions with Sumitomo Mitsui DS Asset Management, Sumitomo Mits...
Star Health Plans Tokyo Meetings With Major Japanese Asset Managers
Star Health & Allied Insurance has scheduled a series of one-on-one meetings with leading institutional investors in Tokyo on September 29, 2026. The sessions with Nomura Asset Management, Daiwa Asset Management, and Tokio Marine Asset Management wil...
Star Health Schedules Virtual Analyst Meet With Eternity Capital
Star Health & Allied Insurance has scheduled a one-to-one virtual meeting with Eternity Capital, an institutional investor, on Wednesday, September 2, 2026, from 11:00 a.m. to 11:45 a.m. The interaction falls under its regulatory disclosure obligatio...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
